AIM ImmunoTech Inc. (AIM)
NYSE · Healthcare
AIM ImmunoTech Inc. Net Income 2009–2025
AIM ImmunoTech Inc. annual/quarterly net income history and growth rate from 2013 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- AIM ImmunoTech Inc. net income for the quarter ending March 31, 2026 was -3.0 M, a 18.41% decrease year-over-year.
- AIM ImmunoTech Inc. net income for the twelve months ending March 31, 2026 was -12.8 M, a 33.19% decrease year-over-year.
- AIM ImmunoTech Inc. annual net income for 2025 was -14.0 M, a 19.41% decrease from 2024.
- AIM ImmunoTech Inc. annual net income for 2024 was -17.3 M, a 40.20% decrease from 2023.
- AIM ImmunoTech Inc. annual net income for 2023 was -29.0 M, a 48.94% increase from 2022.
- AIM ImmunoTech Inc. annual net income for 2022 was -19.4 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
AIM ImmunoTech Inc. Net Income — FAQ
AIM ImmunoTech Inc. (AIM) net income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is AIM ImmunoTech Inc.'s net income?
AIM ImmunoTech Inc. (AIM) reported net income of -$14M for fiscal 2025.
Where can I see AIM's net income history?
The chart and table above show AIM ImmunoTech Inc.'s net income by year and by quarter, including the growth rate.